share_log

Ginkgo Bioworks | 4: Statement of changes in beneficial ownership of securities-Officer Coen Steven P.

SEC announcement ·  Mar 9 06:03
Summary by Futu AI
Steven P. Coen, associated with Ginkgo Bioworks Holdings, Inc. (trading symbol DNA.US), was involved in a transaction on March 7, 2024. The specific details of the transaction, including the action type, status, number of shares, nature of shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. The relationship of Coen to the issuer was noted as 'See remarks,' suggesting a need to refer to additional documentation for clarification.
Steven P. Coen, associated with Ginkgo Bioworks Holdings, Inc. (trading symbol DNA.US), was involved in a transaction on March 7, 2024. The specific details of the transaction, including the action type, status, number of shares, nature of shares, transaction price, and post-transaction shareholding, were not disclosed in the announcement. The relationship of Coen to the issuer was noted as 'See remarks,' suggesting a need to refer to additional documentation for clarification.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.